Effectiveness and Safety of SMART [Spastic Muscle Palpation by Anatomic Landscape for BoNT-A (Botulinumtoxin-A) Injection to Reduce Muscle Tone] BoNT-A Therapy With Dysport® in Patients With Post-stroke Chronic Upper Limb Spasticity (ULS) in Real-life Setting.
← catalyst calendarSponsored by Ipsen (industry) · IPN.PA — their whole pipeline →.
Phase
—
Status
Completed
Study type
Observational
Enrollment
121actual
Sites
31
Country
Germany
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2022-05-09 | actual | When the study began enrolling |
| Primary completion | 2025-04-09 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-07-04 | actual | The whole study's end, after follow-up |
| First posted | 2022-02-04 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-08-01 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Post-Stroke Chronic Upper Limb Spasticity
Primary outcome
what the primary-completion date above is the date OFChange from baseline of Disability Assessment Scale (DAS) score in Principle Target of Treatment (PTT) for the upper limb.
measured At 12 weeks to 16 weeks after injection at Visit 1
Permalink · IPN.PA's whole pipeline · Catalyst calendar · Every registered study · What changed